![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
Vol
5. Issue 13 / April 18, 2005 |
![]() |
||||||
![]() |
![]() |
||||||
![]() |
![]() |
||||||
![]() |
![]() |
![]() |
|||||
![]() |
![]() |
In Brief
The Dart/NYU Biotechnology Achievement Awards recognize the role of leaders who pursue pure science in the development of pharmaceuticals, and particularly honor those scientists whose work has led to major advances at the bedside. Lerner pioneered catalytic antibodies, simultaneously with Scripps Research Professor Peter Schultz, as well as combinatorial antibody libraries. Today, about 55 percent of all new drug applications are antibodies. Lerner graduated from Northwestern University and Stanford Medical School. He served as chair of the Department of Molecular Biology from 1982-86 at the Research Institute of Scripps Clinic (later renamed The Scripps Research Institute) prior to assuming the organization’s presidency. Lerner has received numerous awards and honors, including the Wolf Prize in Chemistry, the California Scientist of the Year Award, the Paul Ehrlich and Ludwig Darmstaedter Prize, and election to the Royal Swedish Academy of Sciences and the National Academy of Sciences. In addition to directing the scientific activities of Scripps Research, Lerner is Lita Annenberg Hazen Professor of Immunochemistry, Cecil H. and Ida M. Green Chair in Chemistry, and a member of The Skaggs Institute for Chemical Biology at Scripps Research.
The celebratory events began with Cochrane's lecture in the Timken Auditorium. Cochrane’s final lecture before his retirement was, appropriately enough, part of the Faculty Lecture Series, a longstanding series of scientific talks he ran for many years. After the lecture, dozens of friends, family, former trainees, and colleagues gathered in the Beckman Atrium for a dinner in his honor. Those giving tributes to Cochrane included Scripps Research Chair of the Board Alice Sullivan, President Richard A. Lerner, and Department of Immunology Chair Richard Ulevitch. A video presentation honoring Cochrane touched on highlights of his distinguished career—including his discovery of KL4, which is being developed as a drug to treat certain types of respiratory distress in infants and adults, and his mentoring of many young scientists. For more information, see the Cochrane faculty page, or go to the Endeavor article "Forty-One Years and Counting".
Payment is by check only. Checks should be made out to "TSRI." For more information, contact Benefits Administration, x4-8487.
TB screening requires a 48 to 72 hour follow-up. Individuals receiving the TB screen on Monday will need to return on Wednesday, and individuals screened on Wednesday, will need to return on Friday. Initiation of the TB screening process will not be available on Friday, but Hepatitis B immunization, serum draws, and tetanus immunizations will be. To learn more about these programs, see the Environmental Health & Safety Occupational Medicine web page, which includes a map and patient information sheets.
Send comments to: mikaono[at]scripps.edu
|
![]() |
|
![]() |
||
![]() |
![]() |
||||||
![]() |